Source: Fierce Healthcare

Baxter: Baxter launches the HEMOPATCH Sealing Hemostat, a room-temperature collagen pad approved for Hemostasis and Sealing.

| Baxter International Inc. (NYSE: BAX), a renowned leader in pioneering surgical innovation, announces the introduction of the Hemopatch Sealing Hemostat available in Europe.

Read full article »
Annual Revenue
$10-50B
Employees
50-100K
Brent Shafer's photo - Interim-CEO of Baxter

Interim-CEO

Brent Shafer

CEO Approval Rating

- -/100

Read more